Not yet recruiting Phase 1 2024-519114-31-00

A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)

Phase 1 – testing safety in a small group of people

Conditions: Treatment-Refractory Rheumatoid Arthritis

Sponsor: Cullinan Therapeutics Inc.

trial.available_in:

БГ

Overview

Trial status: Under evaluation

Who can participate

Age group: 65+ years, 18-64 years Gender: Female, Male Target enrollment: 40 participants

Germany (1)

Italy (1)

Status

Not yet recruiting

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

11.04.2025

Registry ID

2024-519114-31-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.